Recent Headlines
- IIROC Trade Resumption - BE
- Beleave Receives Purchase Order for Cannabis 2.0 Products and Provides Other Operational Updates
- Beleave Provides Update on Company Leadership
- IIROC Trading Halt - BE
- Beleave Announces Election of Board of Directors and AGM 2019 Summary
- Beleave Announces AGM Conference Call Details
- Beleave Announces Joint Venture with Volero Brands to Launch Cannabis 2.0 Products in Canada
- Beleave Receives License to Sell Cannabis Extracts, Topicals and Edibles
- Beleave Announces Date of 2019 Annual General Meeting
- Beleave Appoints Jeannette VanderMarel to Board of Directors
- Beleave Appoints Jeannette VanderMarel Chief Executive Officer
- Beleave Provides Bi-Weekly Default Status Update
- Beleave Announces Operational Updates and Q1 2019 Financials Release Date
- Beleave Provides Bi-Weekly Default Status Update
- Beleave Announces LOI for Leaseback of London Production Facility and Sale of Lloydminster Retail Space
- Beleave Provides Bi-Weekly Default Status Report
- Beleave's New Research License Allows for Further Optimization of Cannabinoids for Capsules and Edibles
- Beleave Announces Sale of Popular Blue Dream Strain
- Beleave Granted Management Cease Trade Order
- IIROC Trade Resumption - BE
- Beleave Announces Non-Binding LOI with TerraFarma Inc.
- Beleave Announces Delay in Filing of Audited Financials
- Beleave Announces Delay in Filing of Audited Financials
- IIROC Trading Halt - BE
- Beleave Commences Sales of Cannabis Oils for the Canadian Adult Use Market
- Beleave Releases Restated Financials with 7% Revenue Increase for the Nine Months Ended December 31, 2018
- Beleave Expands Recreational Cannabis Sales to Saskatchewan
- IIROC Trade Resumption - BE
- Beleave Receives Green Light for Building Permit as Hamilton Phase 2 Expansion Moves Forward
- IIROC Trading Halt - BE
- Beleave Updates Prior Disclosure and Announces Approval of Settlement Agreement with the BCSC
- Beleave Expands Product Line with New Beleave-Branded Product Shipped to the OCS
- Beleave Receives Approval for Hamilton Facility Expansion from City Council
- Beleave Receives Unanimous Approval from Hamilton Planning Committee
- Beleave's Hamilton Expansion Set for Consideration by Planning Committee on May 14
- Beleave Announces Initial Cannabis Oil Sales After Receiving Health Canada Authorization
- Cannabis Stock News Daily Roundup April 8
- Beleave Granted Building Permit for Upcoming London Expansion
- Beleave Announces Board and Management Refresh
- Medi-Green Invites the Community to Grand Opening of its New Clinic in London, Ontario
- Beleave Awarded ISO 9001:2015 Certification as Part of Ongoing Commitment to Improve Efficiency
- Beleave Provides an Update on the BCSC's Temporary Order
- Beleave Announces Executive Management Developments and Provides Activity Updates
- Cannabis Stock News Daily Roundup January 16
- Beleave Receives Health Canada Authorization to Sell Cannabis Oils
- Beleave Provides Update and Clarification on GMP Certification Process
- CORRECTION - Beleave Announces GMP Certification and Operational Updates
- Beleave Announces GMP Certification and Operational Updates
- Beleave Announces GMP Certification and Operational Updates
- Beleave Announces Second Quarter of 2018 Results